Stockreport

Immunome to Present at 13th Annual World ADC London Conference

Immunome, Inc.  (IMNM) 
PDF EXTON, Pa.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop antibo [Read more]